# Cemtrex Inc: overview CETX · Nasdaq · CIK 1435064 · [Industrials](/sectors/industrials.md) · fiscal year ends Sep 30 Pages: [Overview](/companies/cetx.md) · [Financials](/companies/cetx/financials.md) · [Filings](/companies/cetx/filings.md) · [Insiders](/companies/cetx/insiders.md) Latest reported revenue: [$18.4m](/filings/0001493152-26-038337.md) for Q3 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 14, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001493152-26-038337). ## Last eight quarters | Line item | Unit | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [18.1 d](/filings/0001493152-25-029383.md) | [13.7](/filings/0001493152-26-007122.md) | [27.3](/filings/0001493152-26-023803.md) | [17.0](/filings/0001493152-26-038337.md) | [18.5 d](/filings/0001493152-25-029383.md) | [16.1](/filings/0001493152-26-007122.md) | [18.1](/filings/0001493152-26-023803.md) | [18.4](/filings/0001493152-26-038337.md) | | Gross margin | % | [41.8% d](/filings/0001493152-25-029383.md) | [41.5%](/filings/0001493152-26-007122.md) | [44.6%](/filings/0001493152-26-023803.md) | [43.4%](/filings/0001493152-26-038337.md) | [38.0% d](/filings/0001493152-25-029383.md) | [34.8%](/filings/0001493152-26-007122.md) | [37.9%](/filings/0001493152-26-023803.md) | [41.7%](/filings/0001493152-26-038337.md) | | Operating margin | % | [(1.8%) d](/filings/0001493152-25-029383.md) | [(16.6%)](/filings/0001493152-26-007122.md) | [16.9%](/filings/0001493152-26-023803.md) | [(3.8%)](/filings/0001493152-26-038337.md) | [(6.4%) d](/filings/0001493152-25-029383.md) | [(17.4%)](/filings/0001493152-26-007122.md) | [(12.0%)](/filings/0001493152-26-023803.md) | [(6.5%)](/filings/0001493152-26-038337.md) | | Net margin | % | [24.4% d](/filings/0001493152-26-023803.md) | [(209.3%)](/filings/0001493152-26-038337.md) | [31.7%](/filings/0001493152-26-038337.md) | [(27.3%)](/filings/0001493152-26-038337.md) | [(17.3%) d](/filings/0001493152-26-023803.md) | [(127.4%)](/filings/0001493152-26-038337.md) | [5.0%](/filings/0001493152-26-038337.md) | [(24.3%)](/filings/0001493152-26-038337.md) | | Diluted EPS | $ per share | not reported | not reported | not reported | [(5.21)](/filings/0001493152-26-038337.md) | not reported | not reported | not reported | [(3.27)](/filings/0001493152-26-038337.md) | | Free cash flow | $m | [(2.7) d](/filings/0001493152-25-029383.md) | [(2.1)](/filings/0001493152-26-007122.md) | [2.4 d](/filings/0001493152-26-023803.md) | [1.7 d](/filings/0001493152-26-038337.md) | [(3.7) d](/filings/0001493152-25-029383.md) | [(1.1)](/filings/0001493152-26-007122.md) | [(4.6) d](/filings/0001493152-26-023803.md) | [(0.2) d](/filings/0001493152-26-038337.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-09-30) | FY2022 (2022-09-30) | FY2023 (2023-09-30) | FY2024 (2024-09-30) | FY2025 (2025-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [43.1](/filings/0001493152-22-036671.md) | [45.0](/filings/0001493152-23-046365.md) | [59.4](/filings/0001493152-24-052491.md) | [66.9](/filings/0001493152-25-029383.md) | [76.5](/filings/0001493152-25-029383.md) | | Gross margin | % | [39.3%](/filings/0001493152-22-036671.md) | [36.8%](/filings/0001493152-23-046365.md) | [43.3%](/filings/0001493152-24-052491.md) | [41.1%](/filings/0001493152-25-029383.md) | [42.2%](/filings/0001493152-25-029383.md) | | Operating margin | % | [(20.3%)](/filings/0001493152-22-036671.md) | [(31.4%)](/filings/0001493152-23-046365.md) | [(2.5%)](/filings/0001493152-24-052491.md) | [(7.9%)](/filings/0001493152-25-029383.md) | [0.7%](/filings/0001493152-25-029383.md) | | Net margin | % | [18.1%](/filings/0001493152-23-027572.md) | [(28.9%)](/filings/0001493152-24-032245.md) | [(2.5%)](/filings/0001493152-25-011969.md) | [(10.8%)](/filings/0001493152-26-023803.md) | [(36.8%)](/filings/0001493152-26-023803.md) | | Diluted EPS | $ per share | [0.02](/filings/0001493152-22-001976.md) | not reported | not reported | not reported | not reported | | Free cash flow | $m | [(11.1)](/filings/0001493152-22-036671.md) | [(17.9)](/filings/0001493152-23-046365.md) | [(5.0)](/filings/0001493152-24-052491.md) | [(5.2)](/filings/0001493152-25-029383.md) | [(1.8)](/filings/0001493152-25-029383.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cetx/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $101.7k | 33,451 | | New +33,451 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $38.9k | 12,790 | | New +12,790 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $27.7k | 9,120 | | New +9,120 | | [Tower Research Capital LLC (TRC)](/funds/1533421.md) | 2026-06-30 | $2.6k | 849 | | New +849 | | [Strategic Wealth Partners, Ltd.](/funds/1720777.md) | 2026-06-30 | $61 | 20 | | New +20 | | [HARBOUR INVESTMENTS, INC.](/funds/810121.md) | 2026-06-30 | $61 | 20 | | New +20 | | [Beaird Harris Wealth Management, LLC](/funds/1908938.md) | 2026-06-30 | $22 | 7 | | New +7 | | [Allworth Financial LP](/funds/1555170.md) | 2026-06-30 | $4 | 1 | | New +1 | | [FMR LLC](/funds/315066.md) | 2026-06-30 | $3 | 1 | | New +1 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $3 | 1 | | New +1 | ## Recent filings [All 534 filings](/companies/cetx/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-09 | 12:36 ET | [8-K](/filings/0001437749-26-032398.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001437749-26-032398 | | 2026-09-18 | 20:00 ET | [8-K](/filings/0001493152-26-043330.md) | 3.02 Unregistered sale of equity | 0001493152-26-043330 | | 2026-09-16 | 20:00 ET | [8-K/A](/filings/0001493152-26-042895.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001493152-26-042895 | | 2026-08-14 | 20:07 ET | [10-Q](/filings/0001493152-26-038337.md) | Quarterly report, period 2026-06-30 | 0001493152-26-038337 | | 2026-07-06 | 20:51 ET | [8-K](/filings/0001493152-26-032187.md) | 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-032187 | | 2026-06-02 | 20:15 ET | [8-K](/filings/0001493152-26-026874.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-026874 | | 2026-05-15 | 20:16 ET | [10-Q](/filings/0001493152-26-023803.md) | Quarterly report, period 2026-03-31 | 0001493152-26-023803 | | 2026-05-15 | 20:00 ET | [8-K](/filings/0001493152-26-023702.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-023702 | | 2026-03-26 | 20:00 ET | [DEF 14A](/filings/0001493152-26-012901.md) | Proxy statement, period 2026-03-26 | 0001493152-26-012901 | | 2026-03-24 | 20:15 ET | [8-K/A](/filings/0001493152-26-012363.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001493152-26-012363 | ## Latest annual report [Form 10-K for the fiscal year ended Sep 30, 2025](/filings/0001493152-25-029383.md), filed Dec 29, 2025. ## Forecast league Q4 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/893557b9-7649-4de6-8d5d-d8c435f31ac6) ## About the filer - CIK: 1435064 - Tickers: CETX, CETXP - Exchange: Nasdaq - SIC code: 1700 Construction - Special Trade Contractors - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.